115 related articles for article (PubMed ID: 1383353)
1. Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations.
Buckner C; Roberts CR; Foung SK; Lipka J; Reyes GR; Hadlock K; Chan L; Gongora-Biachi RA; Hjelle B; Lal RB
J Infect Dis; 1992 Nov; 166(5):1160-3. PubMed ID: 1383353
[TBL] [Abstract][Full Text] [Related]
2. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
[TBL] [Abstract][Full Text] [Related]
3. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
[TBL] [Abstract][Full Text] [Related]
4. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
Lal RB; Rudolph DL; Kaplan JE; Hjelle B; Levine PH; Coligan JE; Viscidi RP
Virology; 1992 Jan; 186(1):274-9. PubMed ID: 1727602
[TBL] [Abstract][Full Text] [Related]
5. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
Roberts BD; Foung SK; Lipka JJ; Kaplan JE; Hadlock KG; Reyes GR; Chan L; Heneine W; Khabbaz RF
J Clin Microbiol; 1993 Feb; 31(2):260-4. PubMed ID: 8432811
[TBL] [Abstract][Full Text] [Related]
7. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
Lipka JJ; Santiago P; Chan L; Reyes GR; Samuel KP; Blattner WA; Shaw GM; Hanson CV; Sninsky JJ; Foung SK
J Infect Dis; 1991 Aug; 164(2):400-3. PubMed ID: 1856487
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
Catalan-Soares B; Carneiro-Proietti AB; Proietti FA;
Cad Saude Publica; 2005; 21(3):926-31. PubMed ID: 15868051
[TBL] [Abstract][Full Text] [Related]
9. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
Lal RB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S170-8. PubMed ID: 8797720
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
Niazi SK; Bhatti FA; Salamat N
J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
Busch MP; Laycock M; Kleinman SH; Wages JW; Calabro M; Kaplan JE; Khabbaz RF; Hollingsworth CG
Blood; 1994 Feb; 83(4):1143-8. PubMed ID: 8111054
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern.
Biglione MM; Astarloa L; Salomón HE;
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):1-4. PubMed ID: 15665638
[TBL] [Abstract][Full Text] [Related]
13. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians.
Lal RB; Rudolph DL; Nerurkar VR; Yanagihara R
Viral Immunol; 1992; 5(4):265-72. PubMed ID: 1282011
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified western blot containing recombinant envelope glycoproteins.
Brodine SK; Kaime EM; Roberts C; Turnicky RP; Lal RB
Transfusion; 1993; 33(11):925-9. PubMed ID: 7903127
[TBL] [Abstract][Full Text] [Related]
15. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
Tosswill JH; McAlpine L; Mortimer PP
J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
[TBL] [Abstract][Full Text] [Related]
16. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
[TBL] [Abstract][Full Text] [Related]
17. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
[TBL] [Abstract][Full Text] [Related]
18. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
[TBL] [Abstract][Full Text] [Related]
19. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I.
Lal RB; Rudolph DL; Griffis KP; Kitamura K; Honda M; Coligan JE; Folks TM
J Virol; 1991 Apr; 65(4):1870-6. PubMed ID: 2002547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
